[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344737-105":59,"doc-detail-344737-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","multi-omics-analysis-links-fermt1-expression-to-patient-survival-immunotherapy-response-and-metastasis-across-cancers","Multi-omics analysis links FERMT1 expression to patient survival, immunotherapy response, and metastasis across cancers","","Multi-omics analysis evaluates how fermitin family member 1 (FERMT1) expression relates to cancer prognosis, tumor microenvironment status, and metastatic progression. Pan-cancer assessment across 33 cancers uses TCGA and UCSC Xena to quantify expression heterogeneity, genomic alterations, immune infiltration, and drug sensitivity, with LUAD focused on links to tumor classification and survival risk. Functional work in LUAD cell lines tests FERMT1 deletion effects on migration and invasion, supporting FERMT1 as a potential biomarker for immunotherapy response and tumor progression.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-analysis-links-fermt1-expression-to-patient-survival-immunotherapy-response-and-metastasis-across-cancers/344737/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-analysis-links-fermt1-expression-to-patient-survival-immunotherapy-response-and-metastasis-across-cancers/344737.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does FERMT1 expression associate with across cancers in this study?","Question",{"text":113,"@type":114},"High FERMT1 expression correlates with poor prognosis across multiple cancers and is linked to changes in immune cell infiltration and tumor microenvironment-related scores.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was FERMT1 expression analyzed in the pan-cancer and LUAD settings?",{"text":118,"@type":114},"The study used 11,069 patient datasets from 33 cancers via TCGA and the UCSC Xena platform to evaluate expression heterogeneity, prognostic significance, genomic alterations, immune infiltration, and drug sensitivity.",{"name":120,"@type":111,"acceptedAnswer":121},"What functional evidence supports FERMT1’s role in LUAD metastasis?",{"text":122,"@type":114},"Functional assays in LUAD cell lines (NCI-H441 and Calu-3) show that FERMT1 deletion reduces cell migration and invasion.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},344737,1790364982,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Original Article  \nMulti-omics analysis links FERMT1 expression to patient survival, immunotherapy response, and metastasis across cancers  \nPei Chen1\\#, Lu Xiao2,3\\#, Chaoxiang Lv4, Qiqi Zhang4, Yunchuan Wu1,5, Min Chen1  \n1Faculty of Chinese Medicine and State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Macau, China; 2Department of Basic Medicine, Zunyi Medical University, Zhuhai Campus, Zhuhai, China; 3Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, China; 4The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, China; 5College of Acupuncture and Massage, Nanjing University of Chinese Medicine, Nanjing, China  \nContributions: (I) Conception and design: P Chen, L Xiao; (II) Administrative support: M Chen; (III) Provision of study materials or patients: P Chen, Y Wu, M Chen; (IV) Collection and assembly of data: P Chen, Q Zhang; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Yunchuan Wu, PhD. College of Acupuncture and Massage, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Xianlin University Town, Nanjing 210023, China; Faculty of Chinese Medicine and State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Macau, [China. Email: njwych@126.com](China. Email: njwych@126.com); Min Chen, PhD. Faculty of Chinese Medicine and State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau 999078, [China. Email: mchen@must.edu.mo](China. Email: mchen@must.edu.mo).  \nBackground: Accumulating evidence indicates that fermitin family member 1 (FERMT1) is closely related to various disease processes. However, its association with cancer prognosis, tumor microenvironment (TME), and metastatic progression remains unclear, particularly in lung adenocarcinoma (LUAD) . We conducted a comprehensive pan-cancer analysis to evaluate the clinical relevance of FERMT1 expression in LUAD and  \nits functional role in metastasis.  \nMethods: We conducted a multi-omics and functional analysis to evaluate FERMT1 expression across multiple cancer types using 11,069 patient datasets from 33 cancers via The Cancer Genome Atlas (TCGA) database and the University of California, Santa Cruz (UCSC) Xena platform. We assessed FERMT1 expression heterogeneity, prognostic significance, genomic alterations, immune infiltration, and drug sensitivity in pan-cancer and LUAD-specific contexts. Additionally, functional experiments were performed  \nto investigate its role in LUAD cell lines (NCI-H441 and Calu-3) .  \nResults: FERMT1 was significantly overexpressed in 13 tumors and downregulated in 3 compared to normal tissues. Its high expression correlated with poor prognosis in multiple cancers and influenced immune cell infiltration. Genomic alterations in FERMT1 were prevalent across cancers. Pan-cancer analysis revealed significant correlations between FERMT1 expression, TME, and stemness scores. In LUAD, FERMT1 expression was significantly associated with tumor T classification (P=0.001) and higher levels in tumor tissues than in normal tissues. Functional assays demonstrated that FERMT1 deletion reduced LUAD  \ncell migration and invasion.  \nConclusions: FERMT1 serves as a potential biomarker for LUAD prognosis and cancer immunotherapy,  \nhighlighting its role in tumor progression and therapeutic response.  \nKeywords: Pan-cancer; lung adenocarcinoma (LUAD); FERMT1; prognosis; tumor microenvironment (TME)  \nSubmitted Jun 26, 2025. Accepted for publication Nov 14, 2025. Published online Jan 27, 2026.  \ndoi: 10.21037/tcr-2025-1371  \nView this artic","cbCaiuQ0KSIr6Ydc","https://ap.wps.com/l/cbCaiuQ0KSIr6Ydc","pdf",7324717,23,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Introduction\n## Highlight box: Key findings","[{\"question\":\"What does FERMT1 expression associate with across cancers in this study?\",\"answer\":\"High FERMT1 expression correlates with poor prognosis across multiple cancers and is linked to changes in immune cell infiltration and tumor microenvironment-related scores.\"},{\"question\":\"How was FERMT1 expression analyzed in the pan-cancer and LUAD settings?\",\"answer\":\"The study used 11,069 patient datasets from 33 cancers via TCGA and the UCSC Xena platform to evaluate expression heterogeneity, prognostic significance, genomic alterations, immune infiltration, and drug sensitivity.\"},{\"question\":\"What functional evidence supports FERMT1’s role in LUAD metastasis?\",\"answer\":\"Functional assays in LUAD cell lines (NCI-H441 and Calu-3) show that FERMT1 deletion reduces cell migration and invasion.\"}]","Multi-omics analysis links FERMT1 expression to patient survival, immunotherapy response, and metastasis across cancers | PDF",1790055117,58,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15af9fe3afadb15963af0f597f022e37.webp",983,1287,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62988b63128f1682cb52659976f35043.webp",982,1286,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aafc95e35d8d2826ac4d6312784a892d.webp",981,1284,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eeb908856d8c622d759ad70959e6b42b.webp",980,1283]